Insider Transactions Reported by 19 Insiders of Compass Therapeutics, Inc.

Symbol
CMPX on Nasdaq
Location
Boston, MA

Insiders trading volume in the past year

Compass Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Thomas J. Schuetz CHIEF EXECUTIVE OFFICER, Director $43,053,750 +$21,100 +0.05% 08 Feb 2026
Vered Bisker-Leib CHIEF EXECUTIVE OFFICER, Director $4,530,418 08 Feb 2024
Barry Shin Cfo $2,714,250 02 Jan 2026
Neil Lerner Chief Accounting Officer $1,977,525 +$28,400 +1.5% 02 Jan 2026
Jonathan Anderman General Counsel $884,070 +$30,800 +3.6% 02 Jan 2026
Carl L. Gordon Director $0 -$5,678,571 -100% 02 Jan 2026
ORBIMED ADVISORS LLC Director, 10%+ Owner $0 -$5,678,571 -100% 09 Apr 2025
Brett Kaplan Director 18 Feb 2022
David M. Wurzer Director 08 Feb 2023
Stephen P. Squinto Director 18 Feb 2022
Ellen Chiniara Director 02 Jan 2026
Arjun Prasad Chief Commercial Officer 02 Jan 2026
Cynthia Sirard Chief Medical Officer 02 Jan 2026
James P. Boylan Director 02 Jan 2026
Mary Ann Gray Director 02 Jan 2026
Miranda Jayne Toledano Director 25 Jun 2021
Richard S. Lindahl Director 02 Jan 2026
Susan Kalled Chief Scientific Officer 18 Feb 2022
Philip Ferneau Director 02 Jan 2026

Recent Insider Transactions by Companies or Individuals for Compass Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Thomas J. Schuetz CMPX Common Stock Tax liability -0.55% -36,687 6,603,336 08 Feb 2026 Direct
Thomas J. Schuetz CMPX Common Stock Tax liability -0.7% -46,777 6,640,023 09 Jan 2026 Direct
Barry Shin CMPX Common Stock Award 31.2% 125,000 525,000 02 Jan 2026 Direct
Barry Shin CMPX Stock Option (Right to Buy) Award 670,000 670,000 02 Jan 2026 Direct
Cynthia Sirard CMPX STOCK OPTION (RIGHT TO BUY) Award 1,000,000 1,000,000 02 Jan 2026 Direct
Thomas J. Schuetz CMPX Common Stock Award 3.88% 250,000 6,686,800 02 Jan 2026 Direct
Thomas J. Schuetz CMPX Stock Option (Right to Buy) Award 2,000,000 2,000,000 02 Jan 2026 Direct
Arjun Prasad CMPX STOCK OPTION (RIGHT TO BUY) Award 1,000,000 1,000,000 02 Jan 2026 Direct
Richard S. Lindahl CMPX Stock Option (Right to Buy) Award 90,000 90,000 02 Jan 2026 Direct
Ellen Chiniara CMPX Stock Option (Right to Buy) Award 90,000 90,000 02 Jan 2026 Direct
Neil Lerner CMPX Common Stock Award 19.5% 62,500 382,500 02 Jan 2026 Direct
Neil Lerner CMPX Stock Option (Right to Buy) Award 435,000 435,000 02 Jan 2026 Direct
Mary Ann Gray CMPX Stock Option (Right to Buy) Award 90,000 90,000 02 Jan 2026 Direct
James P. Boylan CMPX Stock Option (Right to Buy) Award 90,000 90,000 02 Jan 2026 Direct
Carl L. Gordon CMPX Stock Option (Right to Buy) Award 90,000 90,000 02 Jan 2026 Direct
Philip Ferneau CMPX Stock Option (Right to Buy) Award 90,000 90,000 02 Jan 2026 Direct
Jonathan Anderman CMPX Common Stock Award 714.3% 150,000 171,000 02 Jan 2026 Direct
Jonathan Anderman CMPX Stock Option (Right to Buy) Award 720,000 720,000 02 Jan 2026 Direct
Thomas J. Schuetz CMPX Common Stock Tax liability -0.68% -44,025 6,436,800 16 Nov 2025 Direct
Thomas J. Schuetz CMPX Common Stock Purchase 0.15% $21,100 $2.11 10,000 6,480,825 27 May 2025 Direct
Carl L. Gordon CMPX Common Stock Sale -100% $5,678,571 $1.59 -3,571,428 0 09 Apr 2025 See footnotes
Orbimed Advisors Llc CMPX Common Stock Sale -100% $5,678,571 $1.59 -3,571,428 0 09 Apr 2025 See footnotes
Jonathan Anderman CMPX Common Stock Purchase 2000% $30,800 $1.54 20,000 21,000 07 Apr 2025 Direct
Neil Lerner CMPX Common Stock Purchase 6.67% $28,400 $1.42 20,000 320,000 07 Apr 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.